JP2011520847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520847A5 JP2011520847A5 JP2011508945A JP2011508945A JP2011520847A5 JP 2011520847 A5 JP2011520847 A5 JP 2011520847A5 JP 2011508945 A JP2011508945 A JP 2011508945A JP 2011508945 A JP2011508945 A JP 2011508945A JP 2011520847 A5 JP2011520847 A5 JP 2011520847A5
- Authority
- JP
- Japan
- Prior art keywords
- ethoxy
- xaa
- acetyl
- amino
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 *C(CCC(NCCOCC*CCOCCOCC(NCCCC[C@](C(P)=O)N*)O)O)[N+]([O-])=O Chemical compound *C(CCC(NCCOCC*CCOCCOCC(NCCCC[C@](C(P)=O)N*)O)O)[N+]([O-])=O 0.000 description 8
- XJXNZODHKPMSDQ-PLNGDYQASA-N C/C(/C(C)=O)=C/C(N)=C Chemical compound C/C(/C(C)=O)=C/C(N)=C XJXNZODHKPMSDQ-PLNGDYQASA-N 0.000 description 1
- CVMXXJSHVQQZRG-UHFFFAOYSA-N CC1CCC(CNC(CCCCCCCCCCCCCCCCCCC(O)[U])[U])CC1 Chemical compound CC1CCC(CNC(CCCCCCCCCCCCCCCCCCC(O)[U])[U])CC1 CVMXXJSHVQQZRG-UHFFFAOYSA-N 0.000 description 1
- JRMQQXSMFOBGII-UHFFFAOYSA-N O=CCCCCCCCCCCCCCCCCCNCC1CCCCC1 Chemical compound O=CCCCCCCCCCCCCCCCCCNCC1CCCCC1 JRMQQXSMFOBGII-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08156360.3 | 2008-05-16 | ||
| EP08156360 | 2008-05-16 | ||
| EP09154461 | 2009-03-05 | ||
| EP09154461.9 | 2009-03-05 | ||
| PCT/EP2009/055989 WO2009138511A1 (en) | 2008-05-16 | 2009-05-18 | Long-acting y2 and/or y4 receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011520847A JP2011520847A (ja) | 2011-07-21 |
| JP2011520847A5 true JP2011520847A5 (enExample) | 2012-07-05 |
Family
ID=40934036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508945A Withdrawn JP2011520847A (ja) | 2008-05-16 | 2009-05-18 | 遅効型ｙ２及び／又はｙ４レセプターアゴニスト |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110275559A1 (enExample) |
| EP (1) | EP2279204A1 (enExample) |
| JP (1) | JP2011520847A (enExample) |
| KR (1) | KR20110017874A (enExample) |
| CN (1) | CN102027007A (enExample) |
| AU (1) | AU2009248041B2 (enExample) |
| BR (1) | BRPI0912615A2 (enExample) |
| CA (1) | CA2723855A1 (enExample) |
| IL (1) | IL208836A0 (enExample) |
| MX (1) | MX2010011845A (enExample) |
| RU (1) | RU2504550C2 (enExample) |
| WO (1) | WO2009138511A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5767582B2 (ja) | 2009-07-02 | 2015-08-19 | 武田薬品工業株式会社 | ペプチド及びその用途 |
| WO2011033068A1 (en) * | 2009-09-18 | 2011-03-24 | Novo Nordisk A/S | Long-acting y2 receptor agonists |
| JP2013510829A (ja) * | 2009-11-13 | 2013-03-28 | ノヴォ ノルディスク アー／エス | 長時間作用型ｙ２受容体アゴニスト |
| GB201001333D0 (en) * | 2010-01-27 | 2010-03-17 | Imp Innovations Ltd | Novel compounds and their effects on feeding behaviour |
| US8927687B2 (en) | 2010-07-09 | 2015-01-06 | Amylin Pharmaceuticals, Llc | Microcrystalline Y receptor agonists |
| WO2012080471A1 (en) | 2010-12-16 | 2012-06-21 | Novo Nordisk A/S | Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid |
| MY171146A (en) | 2012-03-22 | 2019-09-27 | Novo Nordisk As | Compositions of glp-1 peptides and preparation thereof |
| PT2991671T (pt) | 2013-05-02 | 2018-11-05 | Novo Nordisk As | Dosagem oral de compostos de glp-1 |
| EP2842965A1 (en) | 2013-09-03 | 2015-03-04 | Gubra ApS | Neuromedin U analogs comprising serum albumin binding amino acid residue |
| KR20160075819A (ko) | 2013-11-15 | 2016-06-29 | 노보 노르디스크 에이/에스 | 선택적 pyy 화합물 및 그것의 사용 |
| HRP20191036T1 (hr) * | 2013-11-15 | 2019-09-06 | Novo Nordisk A/S | Selektivni spojevi pyy i njihova upotreba |
| WO2015073878A1 (en) * | 2013-11-15 | 2015-05-21 | Ur Diet, Llc | Real-time satiety biofeedback |
| WO2015071356A1 (en) | 2013-11-15 | 2015-05-21 | Novo Nordisk A/S | Hpyy(1 -36) having a beta-homoarginine substitution at position 35 |
| KR102393642B1 (ko) | 2014-01-17 | 2022-05-03 | 리플리겐 코포레이션 | 크로마토그래피 컬럼 살균 |
| US20240100450A9 (en) * | 2014-01-17 | 2024-03-28 | Repligen Corporation | Sterilizing chromatography columns |
| US10533039B2 (en) * | 2014-05-21 | 2020-01-14 | President And Fellows Of Harvard College | Ras inhibitory peptides and uses thereof |
| EP3307768B1 (en) * | 2015-06-12 | 2025-01-29 | Novo Nordisk A/S | Selective pyy compounds and uses thereof |
| MA53076B1 (fr) | 2018-02-02 | 2023-11-30 | Novo Nordisk As | Compositions solides comportant un agoniste glp-1, du sel d'acide n-(8-(2-hydroxybenzoyl)amino)caprylate et un lubrifiant |
| TWI749381B (zh) * | 2018-11-01 | 2021-12-11 | 美商美國禮來大藥廠 | 蛋白質酪胺酸-酪胺酸類似物及其使用方法 |
| GB201908426D0 (en) * | 2019-06-12 | 2019-07-24 | Imp College Innovations Ltd | Appetite suppressing compounds |
| IL297368A (en) * | 2020-04-17 | 2022-12-01 | I2O Therapeutics Inc | Long-acting peptide tyrosine kinase (pyy) analogs and methods of use |
| CA3215858A1 (en) | 2021-04-27 | 2022-11-03 | Zhenhuan ZHENG | Combination of bitter receptor agonist and gut-signaling compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2275207C2 (ru) * | 2000-12-14 | 2006-04-27 | Амилин Фармасьютикалз, Инк. | Способ снижения доступности питательного вещества, способ подавления аппетита |
| EP2932981B1 (en) * | 2003-09-19 | 2021-06-16 | Novo Nordisk A/S | Albumin-binding derivatives of GLP-1 |
| WO2005077094A2 (en) * | 2004-02-11 | 2005-08-25 | Amylin Pharmaceuticals, Inc. | Pancreatic polypeptide family motifs and polypeptides comprising the same |
| CA2560174A1 (en) * | 2004-03-17 | 2005-09-29 | 7Tm Pharma A/S | Y4 selective receptor agonists for therapeutic interventions |
| BRPI0512988A (pt) * | 2004-07-08 | 2008-04-22 | Novo Nordisk As | método para aumentar a meia-vida plasmática de uma molécula, composto, uso do mesmo, e, composição farmacêutica |
| KR20080031414A (ko) * | 2005-07-18 | 2008-04-08 | 노보 노르디스크 에이/에스 | 비만치료에 사용하기 위한 신규 펩티드 |
-
2009
- 2009-05-18 KR KR1020107027495A patent/KR20110017874A/ko not_active Withdrawn
- 2009-05-18 RU RU2010149474/04A patent/RU2504550C2/ru not_active IP Right Cessation
- 2009-05-18 WO PCT/EP2009/055989 patent/WO2009138511A1/en not_active Ceased
- 2009-05-18 JP JP2011508945A patent/JP2011520847A/ja not_active Withdrawn
- 2009-05-18 MX MX2010011845A patent/MX2010011845A/es not_active Application Discontinuation
- 2009-05-18 US US12/993,015 patent/US20110275559A1/en not_active Abandoned
- 2009-05-18 BR BRPI0912615A patent/BRPI0912615A2/pt not_active Application Discontinuation
- 2009-05-18 CN CN2009801173043A patent/CN102027007A/zh not_active Withdrawn
- 2009-05-18 CA CA2723855A patent/CA2723855A1/en not_active Withdrawn
- 2009-05-18 AU AU2009248041A patent/AU2009248041B2/en not_active Ceased
- 2009-05-18 EP EP09745843A patent/EP2279204A1/en not_active Withdrawn
-
2010
- 2010-10-20 IL IL208836A patent/IL208836A0/en unknown